A number of new weight loss drugs are under development. Here’s how they work.
The next wave of obesity drugs is coming soon. Pharmaceutical companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound. Some experimental drugs may go beyond diabetes and weight loss, improving liver and heart function while also reducing side effects such as… Read More »